The voices of OCRA’s advocates were amplified by recent television coverage of this year’s Fall Advocacy Day, during which more than 70 people from 30 states met with over 120 Congressional offices to push for critical legislation and funding. Their efforts were broadcast to more than 105,000 viewers, helping to get the message out about the vital … Continued
We are pleased to announce that OCRA’s Chief Program Officer, Sarah DeFeo, has been awarded the inaugural Andrew Godwin Award for Excellence in Community Outreach. Presented by Ovarian Cancer Midwest Focus (OCMF) at University of Minnesota Medical School, the award recognizes DeFeo as an outstanding member in the gynecologic cancer community for her work leading … Continued
A sea of teal washed over the Capitol when more than 70 advocates from 30 states met with over 120 Congressional offices to push for legislative initiatives, including Medicare coverage of life-saving tools such as genetic testing, during OCRA’s 2023 Fall Advocacy Day. Advocacy Day Photos Click to scroll through a full gallery of Advocacy … Continued
Madeleine and Emma Jean may be young, at ages eight and nine, respectively, but they are already focused on how to help create a future in which no families are impacted by ovarian cancer. These two OCRA Heroes have never met but they have a shared motivation for their efforts — losing their namesakes to … Continued
OCRA’s National Conference begins November 1st Join us virtually from November 1st – 3rd for three days of information, community and resources. Attendees will learn the latest updates in research, treatment and care, straight from the experts — in language you don’t have to be a doctor to understand. New this year, our experts will … Continued
Participants in OCRA’s virtual support programs came together for a face-to-face meetup in Chicago this weekend, deepening community connections and highlighting the importance of support programs for those with shared experience in facing gynecologic cancer — no matter how far apart they may live. Co-hosted by OCRA’s Vice President of Support & Education, Tracy Moore, … Continued
OCRA’s Ovarian Cycle Tampa event was in the news this week, shining a well-deserved light on the event’s riders and organizers, and what inspires them to participate in OCRA’s signature fundraising event. The fitness and fundraising event took place on September 30th at CycleBar in Tampa, on the final day of Ovarian Cancer Awareness Month. … Continued
OCRA Announces Game-Changing Initiatives This month, OCRA announced a trio of initiatives that carry profound implications for ovarian cancer and related research and patient support: OCRA will expand its mission to include related gynecologic cancers, will create the first comprehensive ovarian and endometrial cancer registry, and will initiate a groundbreaking international data commons. Audra Moran, President and CEO of … Continued
New York, NY, September 26, 2023 — As Ovarian Cancer Awareness Month draws to a close, Ovarian Cancer Research Alliance (OCRA) is announcing a trio of initiatives that carry profound implications for ovarian cancer and related research and patient support: OCRA will expand its mission to include related gynecologic cancers, will create the first comprehensive ovarian and endometrial cancer … Continued
Snap Summary: Research co-funded by OCRA found that foregoing genetic counseling before and after genetic testing does not negatively impact individuals who do not have a pathogenic mutation. Studies have shown that people who might have a hereditary cancer risk often do not get tested. This makes it important to identify needless barriers that may … Continued
Snap Summary: An OCRA-funded study sought to understand why certain ovarian cancer cells resist olaparib treatment, and discovered that introducing a second drug (mifepristone) while targeting certain cells (polyploid giant cancer cells) may offer a solution. In a study published in the journal Science Advances, researchers at MD Anderson Cancer Center set their sights on … Continued
OCRA is pleased to announce we have once again earned a 4-star rating from Charity Navigator, America’s largest independent charity evaluator. We’re proud to receive the highest possible rating from Charity Navigator, as it reflects our deep commitment to ending ovarian cancer and helping all those affected by a gynecologic cancer. A 4-star rating means that … Continued
Get email updates about research news, action alerts, and ways to join the fight.
